London, UK - EverSphere has announced the release of Milo v8, the newest generation of its empathetic intelligence model, into supervised clinical trials across a network of leading hospitals in North America, Europe, and Asia.
Milo v8 is designed to bridge the gap between medical expertise and human experience, providing clinicians with real-time emotional insight, adaptive dialogue, and patient-support capabilities grounded in rigorous ethical safeguards.
"Healthcare is more than diagnosis and treatment. It’s trust, understanding, and empathy," said Marcus Knox, Founder and CEO of EverSphere. "With Milo v8, we’re bringing those qualities into clinical AI for the first time at true global scale."
The trials will focus on three key areas:
- Patient engagement: Milo v8 can contextualise medical information in plain language, tailoring communication to individual patients.
- Clinical workflow augmentation: By monitoring patient responses and stress indicators, Milo v8 supports doctors and nurses with live insights that can improve bedside manner and treatment adherence.
- Ethical oversight: Every deployment is monitored under EverSphere’s Assurance Framework, led by Dr Abigail Shaw, Director of Ethics and Assurance.
"Milo v8 is about more than efficiency - it’s about dignity," said Shaw. "By embedding ethical review and red-teaming at every stage, we ensure patient safety and humanity remain at the centre of clinical AI."
Milo’s empathetic modelling is built to interoperate with other EverSphere systems, including Kai (optimisation intelligence) and TerraCast (health-environment correlation forecasting). This integrated approach allows hospitals to not only enhance patient interaction, but also anticipate broader health system pressures, from seasonal surges to global pandemics.
The clinical trial programme is being rolled out in partnership with 20+ hospitals across six countries, with initial results expected later this year. Pending successful validation, EverSphere intends to expand Milo v8’s reach into primary care networks and telemedicine platforms, offering a scalable layer of empathetic intelligence in healthcare.
"Technology alone doesn’t heal people," Knox added. "But technology that understands people can transform healthcare forever."
